4DMedical (4DX.AX) Stock Price

4DMedical Price

ASX·CLOSED
4.08AUD-0.28 (-6.64 %)
Market closed

Over the last 8 years 4DMedical grew revenue by 30.8% annually, reaching 5.85 M AUD. For 4DMedical, the net margin of -513.7% is up versus -9,871.2% a few years ago. The consensus 12-month price target for 4DMedical is 3.26 AUD, about 20.0% below where the stock trades today. Of 7 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 750% above its 52-week low.

4DMedical stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of 4DMedical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how 4DMedical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing 4DMedical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

4DMedical Stock Price History
Date4DMedical Price
8/11/20264.08 AUD
8/10/20264.36 AUD
8/7/20264.22 AUD
8/6/20264.70 AUD
8/5/20264.72 AUD
8/4/20264.30 AUD
8/3/20263.94 AUD
7/31/20263.63 AUD
7/30/20263.21 AUD
7/29/20263.26 AUD
7/28/20263.25 AUD
7/27/20263.18 AUD
7/24/20263.11 AUD
7/23/20263.24 AUD
7/22/20263.39 AUD
7/21/20263.42 AUD
7/20/20263.51 AUD
7/17/20263.20 AUD
7/16/20263.79 AUD
7/15/20263.94 AUD
7/14/20263.86 AUD
7/13/20264.04 AUD
7/10/20263.95 AUD
7/9/20264.06 AUD
7/8/20264.10 AUD
7/7/20264.42 AUD
7/6/20264.36 AUD
7/3/20264.09 AUD
7/2/20264.01 AUD
7/1/20264.15 AUD
6/30/20264.43 AUD
6/29/20264.63 AUD
6/26/20264.05 AUD
6/25/20264.54 AUD
6/24/20264.95 AUD
6/23/20264.73 AUD
6/22/20264.72 AUD
6/19/20264.34 AUD
6/18/20263.80 AUD
6/17/20263.80 AUD
6/16/20263.70 AUD
6/15/20263.81 AUD
6/12/20263.63 AUD
6/11/20263.48 AUD
6/10/20263.65 AUD
6/9/20264.01 AUD
6/5/20263.92 AUD
6/4/20263.86 AUD
6/3/20263.79 AUD
6/2/20263.85 AUD
6/1/20264.13 AUD
5/29/20263.71 AUD
5/28/20263.34 AUD
5/27/20263.53 AUD
5/26/20263.32 AUD
5/25/20263.42 AUD
5/22/20263.47 AUD
5/21/20263.37 AUD
5/20/20263.37 AUD
5/19/20263.65 AUD
5/18/20264.00 AUD
5/15/20264.17 AUD
5/14/20263.83 AUD
5/13/20263.38 AUD
5/12/20263.39 AUD
5/11/20263.44 AUD
5/8/20263.21 AUD
5/7/20263.40 AUD
5/6/20263.80 AUD
5/5/20264.02 AUD
5/4/20264.09 AUD
5/1/20264.02 AUD
4/30/20264.01 AUD
4/29/20264.24 AUD
4/28/20264.71 AUD
4/27/20264.97 AUD
4/24/20264.76 AUD
4/23/20265.27 AUD
4/22/20265.12 AUD
4/21/20265.34 AUD
4/20/20265.69 AUD
4/17/20265.84 AUD
4/16/20266.40 AUD
4/15/20266.33 AUD
4/14/20266.31 AUD
4/13/20266.79 AUD
4/10/20266.80 AUD
4/9/20266.29 AUD
4/8/20266.13 AUD
4/7/20265.70 AUD
4/2/20265.64 AUD
4/1/20265.95 AUD
3/31/20265.56 AUD
3/30/20265.64 AUD
3/27/20266.28 AUD
3/26/20266.28 AUD
3/25/20266.23 AUD
3/24/20264.63 AUD
3/23/20264.37 AUD
3/20/20264.30 AUD
3/19/20264.12 AUD
3/18/20263.98 AUD
3/17/20263.79 AUD
3/16/20263.83 AUD
3/13/20264.07 AUD
3/12/20264.22 AUD
3/11/20264.38 AUD
3/10/20264.43 AUD
3/9/20264.06 AUD
3/6/20264.33 AUD
3/5/20264.17 AUD
3/4/20264.05 AUD
3/3/20264.41 AUD
3/2/20264.22 AUD
2/27/20264.00 AUD
2/26/20263.72 AUD
2/25/20263.69 AUD
2/24/20263.60 AUD
2/23/20263.93 AUD
2/20/20263.88 AUD
2/19/20263.74 AUD
2/18/20263.97 AUD
2/17/20263.76 AUD
2/16/20263.80 AUD
2/13/20263.52 AUD
2/12/20263.68 AUD
2/11/20263.85 AUD
2/10/20263.55 AUD
2/9/20263.46 AUD
2/6/20263.10 AUD
2/5/20263.15 AUD
2/4/20263.38 AUD
2/3/20263.70 AUD
2/2/20263.21 AUD
1/30/20263.17 AUD
1/29/20263.43 AUD
1/28/20263.55 AUD
1/27/20263.88 AUD
1/23/20264.05 AUD
1/22/20264.13 AUD
1/21/20264.44 AUD
1/20/20264.36 AUD
1/19/20264.81 AUD
1/16/20265.08 AUD
1/15/20264.53 AUD
1/14/20264.29 AUD
1/13/20264.29 AUD
1/12/20264.29 AUD
1/9/20264.62 AUD
1/8/20264.60 AUD
1/7/20264.69 AUD
1/6/20264.19 AUD
1/5/20264.08 AUD
1/2/20264.54 AUD
12/31/20253.93 AUD
12/30/20254.05 AUD
12/29/20253.74 AUD
12/24/20253.83 AUD
12/23/20253.65 AUD
12/22/20253.57 AUD
12/19/20253.51 AUD
12/18/20252.89 AUD
12/17/20252.83 AUD
12/16/20252.98 AUD
12/15/20252.44 AUD
12/12/20252.22 AUD
12/11/20252.04 AUD
12/10/20252.12 AUD
12/9/20252.00 AUD
12/8/20251.90 AUD
12/5/20251.90 AUD
12/4/20251.84 AUD
12/3/20251.92 AUD
12/2/20251.65 AUD
12/1/20251.75 AUD
11/28/20251.71 AUD
11/27/20251.61 AUD
11/26/20251.60 AUD
11/25/20251.58 AUD
11/24/20251.54 AUD
11/21/20251.42 AUD
11/20/20251.46 AUD
11/19/20251.43 AUD
11/18/20251.49 AUD
11/17/20251.55 AUD
11/14/20251.44 AUD
11/13/20251.47 AUD
11/12/20251.55 AUD
11/11/20251.60 AUD
11/10/20251.63 AUD
11/7/20251.43 AUD
11/6/20251.47 AUD
11/5/20251.51 AUD
11/4/20251.61 AUD
11/3/20251.60 AUD
10/31/20251.74 AUD
10/30/20251.77 AUD
10/29/20251.83 AUD
10/28/20251.79 AUD
10/27/20251.92 AUD
10/24/20251.90 AUD
10/23/20251.99 AUD
10/22/20251.85 AUD
10/21/20251.80 AUD
10/20/20251.73 AUD
10/17/20251.75 AUD
10/16/20251.93 AUD
10/15/20251.84 AUD
10/14/20251.90 AUD
10/13/20252.03 AUD
10/10/20252.22 AUD
10/9/20252.33 AUD
10/8/20252.21 AUD
10/7/20252.26 AUD
10/6/20252.25 AUD
10/3/20252.36 AUD
10/2/20252.11 AUD
10/1/20252.26 AUD
9/30/20251.98 AUD
9/29/20251.80 AUD
9/26/20251.81 AUD
9/25/20251.75 AUD
9/24/20251.53 AUD
9/23/20251.50 AUD
9/22/20251.51 AUD
9/19/20251.66 AUD
9/18/20251.78 AUD
9/17/20251.88 AUD
9/16/20251.75 AUD
9/15/20251.78 AUD
9/12/20251.76 AUD
9/11/20251.89 AUD
9/10/20251.59 AUD
9/9/20251.67 AUD
9/8/20252.31 AUD
9/5/20251.54 AUD
9/4/20251.31 AUD
9/3/20251.15 AUD
9/2/20250.77 AUD
9/1/20250.77 AUD
8/29/20250.57 AUD
8/28/20250.48 AUD
8/27/20250.51 AUD
8/26/20250.55 AUD
8/25/20250.54 AUD
8/22/20250.54 AUD
8/21/20250.56 AUD
8/20/20250.52 AUD
8/19/20250.56 AUD
8/18/20250.57 AUD
8/15/20250.57 AUD
8/14/20250.53 AUD
Access this data via the Eulerpool API
Get Free API Key

4DMedical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
1.05 M AUD
-24.43 M AUD
-24.59 M AUD
Jan 1, 2023
718,600.00 AUD
-31.42 M AUD
-31.46 M AUD
Jan 1, 2024
3.75 M AUD
-34.93 M AUD
-35.98 M AUD
Jan 1, 2025
5.85 M AUD
-36.87 M AUD
-30.07 M AUD
Jan 1, 2026 (e)
8.33 M AUD
-8.33 M AUD
-98.13 M AUD
Jan 1, 2027 (e)
22.27 M AUD
-22.27 M AUD
-36.14 M AUD
Jan 1, 2028 (e)
55.40 M AUD
-55.40 M AUD
-14.36 M AUD
Jan 1, 2029 (e)
90.18 M AUD
-90.18 M AUD
968,642.95 AUD

4DMedical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 13, 2026, 3:14 AM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
2017201820192020202120222023202420252026e2027e2028e2029e
–––1.00–1.00–3.005.008.0022.0055.0090.00
––––––––66.6760.00175.00150.0063.64
–––500.00–500.00–100.00100.00100.00100.00100.00100.00
5.005.005.005.005.005.005.003.005.008.0022.0055.0090.00
-3.00-3.00-6.00-13.00-18.00-24.00-31.00-34.00-36.00-8.00-22.00-55.00-90.00
–––-1,300.00–-2,400.00–-1,133.33-720.00-100.00-100.00-100.00-100.00
-3.00-3.00-6.00-21.00-21.00-24.00-31.00-35.00-30.00-98.00-36.00-14.00–
––100.00250.00–14.2929.1712.90-14.29226.67-63.27-61.11–
264.76264.76264.76264.76261.42294.51300.01370.47424.28424.28424.28424.28424.28
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales 4DMedical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue 4DMedical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare 4DMedical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares 4DMedical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against 4DMedical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

4DMedical stock margins

The 4DMedical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of 4DMedical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for 4DMedical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
57.65 %
-8,658.30 %
-9,871.20 %
Jan 1, 2022
26.61 %
-2,317.57 %
-2,332.63 %
Jan 1, 2023
95.24 %
-4,372.11 %
-4,377.93 %
Jan 1, 2024
93.69 %
-930.43 %
-958.33 %
Jan 1, 2025
92.07 %
-629.86 %
-513.72 %
Jan 1, 2026 (e)
92.07 %
-100.00 %
-1,177.48 %
Jan 1, 2027 (e)
92.07 %
-100.00 %
-162.33 %
Jan 1, 2028 (e)
92.07 %
-100.00 %
-25.92 %

4DMedical Stock Revenue, EBIT, Earnings per Share

The 4DMedical earnings per share therefore indicates how much revenue 4DMedical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.00 AUD
-0.07 AUD
-0.08 AUD
Jan 1, 2022
0.00 AUD
-0.08 AUD
-0.08 AUD
Jan 1, 2023
0.00 AUD
-0.10 AUD
-0.10 AUD
Jan 1, 2024
0.01 AUD
-0.09 AUD
-0.10 AUD
Jan 1, 2025
0.01 AUD
-0.09 AUD
-0.07 AUD
Jan 1, 2026 (e)
0.01 AUD
-0.02 AUD
-0.17 AUD
Jan 1, 2027 (e)
0.04 AUD
-0.05 AUD
-0.06 AUD
Jan 1, 2028 (e)
0.10 AUD
-0.13 AUD
-0.03 AUD

4DMedical business model & stock analysis

4DMedical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

4DMedical historical P/E ratio, EBIT multiple, and P/S ratio

4DMedical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

4DMedical shares outstanding

The number of shares of 4DMedical was 424.28 M in 2025. This indicates how many shares 4DMedical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
261.42 M Stocks
Jan 1, 2022
294.51 M Stocks
Jan 1, 2023
300.01 M Stocks
Jan 1, 2024
370.47 M Stocks
Jan 1, 2025
424.28 M Stocks
Jan 1, 2026 (e)
424.28 M Stocks
Jan 1, 2027 (e)
424.28 M Stocks
Jan 1, 2028 (e)
424.28 M Stocks

Current 4DMedical forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
28.00 %
Buy
71.43 % (5)
Hold
14.29 % (1)
Sell
14.29 % (1)
12M Price Target
3.26
Last Price
4.08
Currency
AUD
12M Return Potential
-20.00 %
LTM Return
0 %

4DMedical shareholder structure

% Name
11.38126%
Fouras (Andreas)
Fouras (Andreas)
0.16574%
BetaShares Capital Ltd.
BetaShares Capital Ltd.
0.04286%
DFA Australia Ltd.
DFA Australia Ltd.
0.00899%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.

4DMedical Beneficial Ownership Filings (SEC 13D/G)

Free Float
73.8%
Float Shares
-
Shares Outstanding
-

4DMedical Executives and Management Board

9 members · 22 % women

AF

Dr. Andreas Fouras

Chief Executive Officer, Managing Director, Executive Director

1.29 M AUD

Management

CC

Mr. Chris Cox

Interim Chief Financial Officer

–
HG

Mr. Hamish George

Company Secretary

–
SH

Mr. Simon Hinsley

Investor Relations · since 2021

–

Board of Directors

JS

Mr. Julian Sutton

Non-Executive Independent Director

382,017.00 AUD
JL

Mr. John Livingston

Non-Executive Director · since 2018

170,464.00 AUD
RF

Dr. Robert Figlin

Non-Executive Independent Director

50,000.00 AUD
LB

Ms. Lilian Bianchi

Non-Executive Chairman of the Board

22,667.00 AUD
GM

Ms. Geraldine Mcginty

Non-Executive Director

–

4DMedical Supply Chain

4DMedical Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
E&P Financial Group
Supplier·Capital Markets·AU
-0.29
-0.16
0.51
-0.04
0.34
—

Frequently asked questions about 4DMedical

Analysts currently set an average price target of 3.47 AUD for the 4DMedical stock (median: 3.26 AUD), implying -15.0 % versus the latest price. The consensus is based on 7 analyst ratings.

4DMedical Analyst Price Targets 2026

7 analysts currently rate the 4DMedical stock: 5 recommend buying, 1 holding and 1 selling. For 2026, analysts expect 4DMedical to generate revenue of 8.33 M AUD and earnings per share of -0.23 AUD.

4DMedical Analyst Price Targets 2026

Converted at the current exchange rate, the 4DMedical share trades at 2.50 EUR (4.08 AUD).

The 4DMedical share (4DX.AX) is listed on 2 stock exchanges, including: ASX (4DX.AX).

No history available for 4DMedical.

The expected revenue of 4DMedical is 8.33 M AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of 4DMedical is -98.13 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of 4DMedical is currently -17.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the 4DMedical stock.

The price-to-sales ratio (P/S) of 4DMedical is currently 207.70. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the 4DMedical stock.

The Eulerpool Quality Score for 4DMedical is 3/10.

The ISIN of 4DMedical is AU0000095416. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of 4DMedical is 4DX.AX. The ticker symbol is used to trade 4DMedical shares on the stock exchange.

4DMedical paid dividends every year for the past 0 years.

4DMedical is assigned to the 'Health' sector.

The dividends of 4DMedical are distributed in AUD.

All fundamentals and in-depth analysis of 4DMedical

Our stock analysis for 4DMedical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 4DMedical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

4DMedical Stock
4DMedical Revenue→
4DMedical Stock
4DMedical Net Income→
4DMedical Stock
4DMedical P/E→
4DMedical Stock
4DMedical P/S→
4DMedical Stock
4DMedical EBIT→
4DMedical Stock
4DMedical Dividend→
4DMedical Stock
4DMedical Directors Dealings→
4DMedical Stock
4DMedical Stocks→
4DMedical Stock
4DMedical Market capitalization→
4DMedical Stock
4DMedical Debt→
4DMedical Stock
4DMedical Liabilities→
4DMedical Stock
4DMedical Equity→
4DMedical Stock
4DMedical AAQS→
4DMedical Stock
4DMedical Employees→
4DMedical Stock
4DMedical ROE→
4DMedical Stock
4DMedical ROA→
4DMedical Stock
4DMedical ROCE→
4DMedical Stock
4DMedical News→
4DMedical Stock
4DMedical Analyst Price Targets→

Health Stocks

60 Degrees Pharmaceuticals4D Molecular Therapeutics9 Meters Biopharma4BasebioA Plus Biotechnology Co3SBioAap Implantate3D MedicinesAardvark Therapeutics3D Global BiotechAarey Drugs and Pharmaceuticals3-D MatrixAll Stocks A–Z →